Serological markers to measure recent changes in malaria at population level in Cambodia

BackgroundSerological markers for exposure to different Plasmodium species have recently been used in multiplex immunoassays based on the Luminex technology. However, interpretation of the assay results requires consideration of the half-life of specific antibodies against these markers. Therefore, the aim of the present study was to document the half-life of malaria specific serological makers, as well as assessing the sensitivity of these markers to pick up recent changes in malaria exposure.MethodsA recently developed multiplex immunoassay was used to measure the intensity of antibody (Ab) responses against 19 different Plasmodium specific antigens, covering different human malaria parasites and two vector saliva antigens. Therefore, 8439 blood samples from five cross-sectional surveys in Ratanakiri, Cambodia, were analysed. These involve a random selection from two selected surveys, and an additional set of blood samples of individuals that were randomly re-sampled three, four or five times. A generalized estimating equation model and linear regression models were fitted on log transformed antibody intensity data.ResultsResults showed that most (17/21) Ab-responses are higher in PCR positive than PCR negative individuals. Furthermore, these antibody-responses follow the same upward trend within each age group. Estimation of the half-lives showed differences between serological markers that reflect short- (seasonal) and long-term (year round) transmission trends. Ab levels declined significantly together with a decrease of PCR prevalence in a group of malaria endemic villages.ConclusionFor Plasmodium falciparum, antibodies against LSA3.RE, GLURP and Pf.GLURP.R2 are most likely to be a reflexion of recent (range from 6 to 8 months) exposure in the Mekong Subregion. PvEBP is the only Plasmodium vivax Ag responding reasonably well, in spite of an estimated Ab half-life of more than 1 year. The use of Ab intensity data rather dichotomizing the continuous Ab-titre data (positive vs negative) will lead to an improved approach for serological surveillance.

[1]  Chris Drakeley,et al.  Serology: a robust indicator of malaria transmission intensity? , 2007, Trends in parasitology.

[2]  B. Cissé,et al.  Novel Peptide Marker Corresponding to Salivary Protein gSG6 Potentially Identifies Exposure to Anopheles Bites , 2008, PloS one.

[3]  V. A. Stewart,et al.  Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands , 2012, BMC Infectious Diseases.

[4]  A. Juillerat,et al.  Allelic Diversity of the Plasmodium falciparum Erythrocyte Membrane Protein 1 Entails Variant-Specific Red Cell Surface Epitopes , 2011, PloS one.

[5]  C. Rogier,et al.  A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens , 2010, Malaria Journal.

[6]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[7]  J. Hodges,et al.  Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. , 2014, The Journal of infectious diseases.

[8]  D. Conway,et al.  Dynamics of the antibody response to Plasmodium falciparum infection in African children. , 2014, The Journal of infectious diseases.

[9]  A. Ghani,et al.  Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion Rates , 2009, PloS one.

[10]  S. Krudsood,et al.  Malaria diagnosis: a brief review. , 2009, The Korean journal of parasitology.

[11]  T. Triglia,et al.  Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species , 2000, Molecular Microbiology.

[12]  Saorin Kim,et al.  Plasmodium knowlesi Infection in Humans, Cambodia, 2007–2010 , 2011, Emerging infectious diseases.

[13]  T. Weppelmann,et al.  Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti , 2014, Malaria Journal.

[14]  Ziv Shkedy,et al.  Modeling Infectious Disease Parameters Based on Serological and Social Contact Data , 2012 .

[15]  Teun Bousema,et al.  Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination , 2013, PLoS medicine.

[16]  K. Lindblade,et al.  Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994–2009 , 2014, Malaria Journal.

[17]  Jae Won Lee,et al.  OutlierD: an R package for outlier detection using quantile regression on mass spectrometry data , 2008, Bioinform..

[18]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[19]  Søren Højsgaard,et al.  The R Package geepack for Generalized Estimating Equations , 2005 .

[20]  Richard J Maude,et al.  Spatial and temporal epidemiology of clinical malaria in Cambodia 2004–2013 , 2014, Malaria Journal.

[21]  M. Theisen,et al.  Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing. , 2000, Vaccine.

[22]  G. Fouda,et al.  Multiplex Assay for Simultaneous Measurement of Antibodies to Multiple Plasmodium falciparum Antigens , 2006, Clinical and Vaccine Immunology.

[23]  Peter D. Crompton,et al.  The Plasmodium falciparum-Specific Human Memory B Cell Compartment Expands Gradually with Repeated Malaria Infections , 2010, PLoS pathogens.

[24]  V. Machault,et al.  Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants , 2012, Malaria Journal.

[25]  L. BenMohamed,et al.  Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. , 1994, Journal of immunology.

[26]  P. Siba,et al.  Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response , 2014, Infection and Immunity.

[27]  L. Hviid,et al.  Trying to remember: immunological B cell memory to malaria. , 2015, Trends in parasitology.

[28]  S. Sovannaroth,et al.  Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria: a cluster randomised controlled trial. , 2016, The Lancet. Infectious diseases.

[29]  M. Whittaker,et al.  Malaria elimination without stigmatization: a note of caution about the use of terminology in elimination settings , 2014, Malaria Journal.

[30]  W. Hawley,et al.  Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren , 2013, Malaria Journal.

[31]  M. White,et al.  Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity , 2016, Scientific Reports.

[32]  D. Drew,et al.  Research priorities for the development and implementation of serological tools for malaria surveillance , 2014, F1000prime reports.

[33]  HyungJun Cho,et al.  Outlier Detection using Projection Quantile Regression for Mass Spectrometry Data with Low Replication , 2012, BMC Research Notes.

[34]  D. Conway,et al.  Serology describes a profile of declining malaria transmission in Farafenni, The Gambia , 2015, Malaria Journal.

[35]  Peter D. Crompton,et al.  Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities , 2015, Proceedings of the National Academy of Sciences.

[36]  J. Simpson,et al.  New Insights into Acquisition, Boosting, and Longevity of Immunity to Malaria in Pregnant Women , 2012, The Journal of infectious diseases.

[37]  C. Sutherland.  Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets? , 2009, Molecular and biochemical parasitology.

[38]  D. Kwiatkowski,et al.  Prevalence and Boosting of Antibodies to Plasmodium falciparum Glycosylphosphatidylinositols and Evaluation of Their Association with Protection from Mild and Severe Clinical Malaria , 2002, Infection and Immunity.

[39]  C. Drakeley,et al.  Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. , 2009, Advances in parasitology.

[40]  C. Rogier,et al.  Assessment of exposure to Plasmodium falciparum transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assays , 2011, Parasites & Vectors.

[41]  Peter D. Crompton,et al.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. , 2014, Annual review of immunology.

[42]  Anne M Johnson,et al.  Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE) , 2013, PLoS medicine.

[43]  T. Theander,et al.  A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma , 2008, Malaria Journal.

[44]  J. Vuust,et al.  Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli , 1995, Clinical and diagnostic laboratory immunology.

[45]  S. Sovannaroth,et al.  Implementation and application of a multiplex assay to detect malaria-specific antibodies: a promising tool for assessing malaria transmission in Southeast Asian pre-elimination areas , 2015, Malaria Journal.

[46]  D. Serre,et al.  Whole Genome Sequencing of Field Isolates Reveals a Common Duplication of the Duffy Binding Protein Gene in Malagasy Plasmodium vivax Strains , 2013, PLoS neglected tropical diseases.

[47]  N. Khim,et al.  Large-scale malaria survey in Cambodia: Novel insights on species distribution and risk factors , 2007, Malaria Journal.

[48]  I. Vigan-Womas,et al.  Analysis of antibody profiles in symptomatic malaria in three sentinel sites of Ivory Coast by using multiplex, fluorescent, magnetic, bead-based serological assay (MAGPIX™) , 2015, Malaria Journal.

[49]  H. D. del Portillo,et al.  Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay , 2010, Malaria Journal.

[50]  U. d’Alessandro,et al.  Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia , 2012, Malaria Journal.

[51]  David L. Smith,et al.  A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010 , 2012, PLoS neglected tropical diseases.

[52]  R. Sauerwein,et al.  How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. , 2013, Trends in parasitology.

[53]  J. McCarthy,et al.  Using serological measures to monitor changes in malaria transmission in Vanuatu , 2010, Malaria Journal.

[54]  J. Rayner,et al.  Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library , 2014, Malaria Journal.

[55]  Koen Peeters Grietens,et al.  An innovative tool for moving malaria PCR detection of parasite reservoir into the field , 2013, Malaria Journal.

[56]  M. Coosemans,et al.  Malaria transmission and major malaria vectors in different geographical areas of Southeast Asia , 2004, Tropical medicine & international health : TM & IH.

[57]  J. Cox,et al.  Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  F B Hu,et al.  Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. , 1998, American journal of epidemiology.

[59]  I. Kleinschmidt,et al.  Serological Markers Suggest Heterogeneity of Effectiveness of Malaria Control Interventions on Bioko Island, Equatorial Guinea , 2011, PloS one.

[60]  D. Conway,et al.  IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life , 2007, Malaria Journal.

[61]  D. Serre,et al.  De Novo Assembly of a Field Isolate Genome Reveals Novel Plasmodium vivax Erythrocyte Invasion Genes , 2013, PLoS neglected tropical diseases.

[62]  J. Priest,et al.  Serological Measures of Malaria Transmission in Haiti: Comparison of Longitudinal and Cross-Sectional Methods , 2014, PloS one.

[63]  Koen Peeters Grietens,et al.  Spatial clustering and risk factors of malaria infections in Ratanakiri Province, Cambodia , 2014, Malaria Journal.

[64]  C. King,et al.  High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[65]  C. Coban,et al.  Serologic Markers in Relation to Parasite Exposure History Help to Estimate Transmission Dynamics of Plasmodium vivax , 2011, PloS one.

[66]  Nancy Fullman,et al.  The changing epidemiology of malaria elimination: new strategies for new challenges , 2013, The Lancet.

[67]  Babacar Faye,et al.  Immunogenicity of ChAd63 + MVA ME-TRAP in Senegalese adults , 2014, Malaria Journal.

[68]  L. Okell,et al.  Long-Lived Antibody and B Cell Memory Responses to the Human Malaria Parasites, Plasmodium falciparum and Plasmodium vivax , 2010, PLoS pathogens.

[69]  E. Angov,et al.  Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation , 2014, Malaria Journal.

[70]  J. Barnwell,et al.  Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission , 2015, Malaria Journal.

[71]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[72]  D. Altman,et al.  Multiple significance tests: the Bonferroni method , 1995, BMJ.

[73]  Niel Hens,et al.  Living on Three Time Scales: The Dynamics of Plasma Cell and Antibody Populations Illustrated for Hepatitis A Virus , 2012, PLoS Comput. Biol..

[74]  C. Rogier,et al.  Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers. , 2006, The American journal of tropical medicine and hygiene.

[75]  Jason Fine,et al.  Estimating equations for association structures , 2004, Statistics in medicine.

[76]  C. John,et al.  Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens , 2012, Malaria Journal.